Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation

References

• Bode AM, Dong Z. The two faces of capsaicin. Cancer Res 2011;71:2809–14.
   PubMed Web of Science ®Google Scholar
• Perucka I, Oleszek W. Extraction and determination of capsaicinoids in fruit of hot pepper Capsicum annuum L. by spectrophotometry and high-performance liquid chromatography. Food Chem 2000;71:287–91.
   Web of Science ®Google Scholar
• Hayman M, Kam PCA. Capsaicin: a review of its pharmacology and clinical applications. Curr Anaesth Crit Care 2008;19:338–43.
   Google Scholar
• Josse AR, Sherriffs SS, Holwerda AM, et al. Effects of capsinoid ingestion on energy expenditure and lipid oxidation at rest and during exercise. Nutr Metab (Lond) 2010;7:65–74.
   PubMed Web of Science ®Google Scholar
• Belza A, Frandsen E, Kondrup J. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Int J Obes (Lond) 2007;31:121–30.
   PubMed Web of Science ®Google Scholar
• Hachiya S, Kawabata F, Ohnuki K, et al. Effects of CH-19 Sweet, a non-pungent cultivar of red pepper, on sympathetic nervous activity, body temperature, heart rate, and blood pressure in humans. Biosci Biotechnol Biochem 2007;71:671–6.
   PubMed Web of Science ®Google Scholar
• Lim K, Yoshioka M, Kikuzato S, et al. Dietary red pepper ingestion increases carbohydrate oxidation at rest and during exercise in runners. Med Sci Sports Exerc 1997;29:355–61.
   PubMed Web of Science ®Google Scholar
• Nabekura T, Kamiyama S, Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 2005;327:866–70.
   PubMed Web of Science ®Google Scholar
• Okura T, Ibe M, Umegaki K, et al. Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. Biol Pharm Bull 2010;33:255–9.
   PubMed Web of Science ®Google Scholar
• Han Y, Tan TM, Lim LY. Effects of capsaicin on P-gp function and expression in Caco-2 cells. Biochem Pharmacol 2006;71:1727–34.
   PubMed Web of Science ®Google Scholar
• Tsukura Y, Mori M, Hirotani Y, et al. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells. Biol Pharm Bull 2007;30:1982–6.
   PubMed Web of Science ®Google Scholar
• Zhai XJ, Shi F, Chen F, Lu YN. Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition. Food Chem Toxicol 2013;62:323–8.
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361–98.
   PubMed Web of Science ®Google Scholar
• Matheny CJ, Lamb MW, Brouwer KR, Pollack GM. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy 2001;21:778–96.
   PubMed Web of Science ®Google Scholar
• Simpson K, Jarvis B. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 2000;59:301–21.
   PubMed Web of Science ®Google Scholar
• Jin MJ, Han HK. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. J Food Sci 2010;75:H93–6.
   PubMed Web of Science ®Google Scholar
• Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 2001;21:15–23.
   PubMed Web of Science ®Google Scholar
• Ruan LP, Chen S, Yu BY, et al. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem 2006;41:605–10.
   PubMed Web of Science ®Google Scholar
• Wada S, Kano T, Mita S, et al. The role of inter-segmental differences in P-glycoprotein expression and activity along the rat small intestine in causing the double-peak phenomenon of substrate plasma concentration. Drug Metab Pharmacokinet 2013;28:98–103.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Yellu NR, Neerati P. Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: involvement of P-glycoprotein inhibition. Pharmacol Rep 2016;68:338–43.
   PubMed Web of Science ®Google Scholar
• Salphati L, Childers K, Pan L, et al. Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J Pharm Pharmacol 2001;53:1007–13.
   PubMed Web of Science ®Google Scholar
• Neerati P, Ganji D, Bedada SK. Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats. Eur J Pharm Sci 2011;44:27–31.
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. J Pharm Sci 2005;94:1694–704.
   PubMed Web of Science ®Google Scholar
• Sutton SC, Rinaldi MT, Vukovinsky KE. Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS Pharm Sci 2001;3:E25.
   PubMedGoogle Scholar
• Voruganti S, Yamsani SK, Ravula SK, et al. Effect of pomegranate juice on intestinal transport and pharmacokinetics of nitrendipine in rats. Phytother Res 2012;26:1240–5.
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Neway WE, Ohe T, et al. In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. J Pharmacol Exp Ther 2001;296:723–35.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Barve A. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 1998;15:1792–5.
   PubMed Web of Science ®Google Scholar
• Takara K, Ohnishi N, Horibe S, Yokoyama T. Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine. Drug Metab Dispos 2003;31:1235–9.
   PubMed Web of Science ®Google Scholar
• Perloff MD, von Moltke LL, Greenblatt DJ. Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir. J Clin Pharmacol 2002;42:1269–74.
   PubMed Web of Science ®Google Scholar
• Cvetkovic M, Leake B, Fromm MF, et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999;27:866–71.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhai X, Zhu C, Lu Y. Effects of capsaicin on pharmacokinetics of pitavastatin in rats. Xenobiotica 2015;45:171–6.
   PubMed Web of Science ®Google Scholar
• Neerati P, Bedada SK. Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats. Pharmacol Rep 2015;67:339–44.
   PubMed Web of Science ®Google Scholar